|
Number and percent of patients with infection- related clinical syndromes covered by the studied PDA programs as of January 2004. |
||||||||
| Major Clinical Syndromes |
Patients |
SG |
QID |
JHABx |
5MCC |
5MID |
PMID |
Total % Rec |
|
|
||||||||
| Fever |
6 |
6 |
6 |
6 |
4 |
4 |
4 |
100 |
| Upper Respiratory |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
100 |
| Pleuropulmonary |
71 |
71 |
71 |
71 |
71 |
69 |
31 |
100 |
| Urinary Tract |
22 |
22 |
22 |
22 |
22 |
22 |
0 |
100 |
| Sepsis |
3 |
3 |
3 |
3 |
3 |
3 |
0 |
100 |
| Peritonitis |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
100 |
| Cardiovascular |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
100 |
| Central Nervous System |
8 |
8 |
8 |
8 |
8 |
8 |
7 |
100 |
| Soft Tissue |
42 |
42 |
42 |
42 |
42 |
42 |
40 |
100 |
| Gastrointestinal |
27 |
27 |
27 |
27 |
27 |
27 |
7 |
100 |
| Bone and Joint |
9 |
9 |
9 |
9 |
9 |
9 |
8 |
100 |
| STD |
1 |
1 |
1 |
0 |
0 |
1 |
0 |
100 |
| Eye |
2 |
2 |
2 |
2 |
2 |
0 |
2 |
100 |
| HIV |
6 |
6 |
6 |
6 |
0 |
0 |
0 |
100 |
| TOTALS |
202 |
202 |
202 |
201 |
195 |
192 |
106 |
202 |
| TOTAL % |
100 |
100 |
99 |
97 |
95 |
52 |
100 |
|
| 95% Confidence Intervals |
100% |
100% |
97.5% to 100% |
94.5% to 99.5% |
92% to 98% |
45% to 59% |
||
Burdette et al. Annals of Clinical Microbiology and Antimicrobials 2004 3:22 doi:10.1186/1476-0711-3-22 |
||||||||